## DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsLiabilitiesDetails

**Year Ended**

|  | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| --- | --- | --- | --- |
| **  Deferred tax assets:** |  |  |  |
|     Net operating loss carry-forwards |  |  |  |
|     Research and development credits |  |  |  |
| *      State* |  |  |  |
| *      Federal* |  |  |  |
|     Other tax credits and attributes |  |  |  |
|     Deferred revenue |  |  |  |
|     Inventory and warranty reserves |  |  |  |
|     Stock-based compensation |  |  |  |
|     Operating lease right-of-use liabilities |  |  |  |
|     Capitalized research and development costs |  |  |  |
|     Deferred GILTI tax assets |  |  |  |
|     Accruals and others |  |  |  |
|     Total deferred tax assets |  |  |  |
|     Valuation allowance |  |  |  |
|     Deferred tax assets, net of valuation allowance |  |  |  |
| *      Foreign jurisdictions* |  |  |  |
| **  Deferred tax liabilities:** |  |  |  |
|     Depreciation and amortization |  |  |  |
|     Investment in certain financing funds |  |  |  |
|     Operating lease right-of-use assets |  |  |  |
|     Deferred revenue |  |  |  |
|     Other |  |  |  |
|     Total deferred tax liabilities |  |  |  |
|     Deferred tax assets (liabilities), net of valuation allowance |  |  |  |